| 2025-08-15 19:10 | CC:ONC | Oncolytics Biotech Inc (2) | 1.49 | Shares Delisted from TSX222 | Oncolytics Biotech to be delisted from TSX Aug. 22 |
| 2025-08-08 09:30 | CC:ONC | Oncolytics Biotech Inc (2) | 1.26 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-08-08 09:25 | CC:ONC | Oncolytics Biotech Inc (2) | 1.26 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-07-08 08:50 | CC:ONC | ONCOLYTICS BIOTECH INC. | 1.37 | News Release200 | Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies |
| 2025-05-14 16:52 | CC:ONC | Oncolytics Biotech Inc (2) | 0.71 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-05-14 16:52 | CC:ONC | Oncolytics Biotech Inc (2) | 0.71 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-03-11 09:10 | CC:ONC | Oncolytics Biotech Inc (2) | 0.895 | In the News525 | Globe says Miehm reaffirms Oncolytics at "outperform" |
| 2025-03-07 13:28 | CC:ONC | Oncolytics Biotech Inc (2) | 1.08 | SEDAR Annual Report803 | SEDAR Annual Report |
| 2025-03-07 13:23 | CC:ONC | Oncolytics Biotech Inc (2) | 1.08 | SEDAR MD & A815 | SEDAR MD & A |
| 2025-03-07 13:17 | CC:ONC | Oncolytics Biotech Inc (2) | 1.08 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2025-02-25 09:27 | CC:ONC | Oncolytics Biotech Inc (2) | 1.02 | News Release200 | Oncolytics Biotech to hold 2024 results call March 7 |
| 2025-02-19 17:59 | CC:ONC | Oncolytics Biotech Inc (2) | 1.03 | News Release200 | Oncolytics gets green light to continue study enrolment |